Martin C. Wright
22Patents
13h-index
34Co-inventors
81Inventor score
Filing activity: Oct 26, 1994 → Sep 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6846655B1 | Methods for generating highly diverse libraries | Emerging Cross-Sectional Technologies | 65 | Expired |
| US7858739B2 | Inhibitors of type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 62 | Active |
| US7847062B2 | Pharmacokinetic modulation and compositions for modified FN3 polypeptides | Chemistry; Metallurgy | 59 | Active |
| US8324362B2 | Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 57 | Active |
| US8343501B2 | Bispecific EGFR/IGFIR binding molecules | Chemistry; Metallurgy | 41 | Active |
| US8470332B2 | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR | Chemistry; Metallurgy | 39 | Active |
| US8609613B2 | Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides | Chemistry; Metallurgy | 35 | Active |
| US9017655B2 | Bispecific EGFR/IGFIR binding molecules | Chemistry; Metallurgy | 34 | Active |
| US9328157B2 | Inhibitors of type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 26 | Active |
| US9771411B2 | Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules | Chemistry; Metallurgy | 22 | Active |
| US9862758B2 | Inhibitors of type 2 vascular endothelial growth factor receptors | Chemistry; Metallurgy | 20 | Active |
| US6623926B1 | Methods for producing 5′-nucleic acid-protein conjugates | Human Necessities | 14 | Expired |
| US10406251B2 | PD-L1 binding polypeptides for imaging | Physics | 14 | Active |
| US10221232B2 | Methods of treating cancer by administering IGF-IR binding molecules | Chemistry; Metallurgy | 7 | Active |
| US10183987B2 | Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules | Chemistry; Metallurgy | 7 | Active |
| US5650294A | Isolated promoter and terminator of elongation factor 1-.alpha. | Chemistry; Metallurgy | 4 | Expired |
| US11344639B2 | PET imaging with PD-L1 binding polypeptides | Chemistry; Metallurgy | 3 | Active |
| US11173219B2 | PD-L1 binding polypeptides for imaging | Physics | 3 | Active |
| US11149077B2 | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR | Chemistry; Metallurgy | 1 | Active |
| US10995131B2 | Libraries of modified fibronectin type III tenth domain-containing polypeptides | Chemistry; Metallurgy | 1 | Active |
| US10954286B2 | Bispecific EGFR/IGFIR binding molecules | Chemistry; Metallurgy | 1 | Active |
| US12194110B2 | PD-L1 binding polypeptides for imaging | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.